Insiders · TLSI

TLSI insider transactions

TriSalus Life Sciences Inc. (TLSI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for TLSI

• 21d
  Chief Commercial Officer Marshak Richard sold $1,450 worth of shares (543 units at $2.67), decreasing direct ownership by 0.43% to 125,101 units (SEC Form 4) to cover withholding tax

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 22d
  Director Wahlstrom Mats bought $151,800 worth of shares (60,000 units at $2.53), increasing direct ownership by 69% to 147,555 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 22d
  Director Stansky Michael P bought $1,525,000 worth of shares (610,000 units at $2.50), increasing direct ownership by 49% to 1,240,722 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 22d
  Chief Financial Officer Patience David bought $17,253 worth of shares (7,100 units at $2.43), increasing direct ownership by 3% to 275,757 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 22d
  CEO and President Szela Mary T bought $102,776 worth of shares (39,682 units at $2.59), increasing direct ownership by 4% to 1,065,215 units (SEC Form 4) to cover withholding tax

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 22d
  Director Gordon Gary B. bought $24,600 worth of shares (10,000 units at $2.46), increasing direct ownership by 16% to 72,510 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 25d
  Director Gordon Gary B. was granted 52,754 shares, increasing direct ownership by 541% to 62,510 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 25d
  Director Hicks Kerry R was granted 28,201 shares, increasing direct ownership by 5% to 542,790 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 25d
  Director Wahlstrom Mats was granted 71,828 shares, increasing direct ownership by 457% to 87,555 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 25d
  Director Stansky Michael P was granted 43,590 shares, increasing direct ownership by 6% to 830,722 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 25d
  Director Valle William was granted 52,754 shares, increasing direct ownership by 173% to 83,241 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 25d
  Director Matlin David J was granted 51,266 shares, increasing direct ownership by 4% to 1,323,210 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 50d
  SEC Form 4 filed by Frankenius Equity Ab

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 69d
  SEC Form 4 filed by Matlin David J

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 81d
  SEC Form 4 filed by Cox Bryan F.

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 81d
  SEC Form 4 filed by Devlin Jodi

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 81d
  SEC Form 4 filed by Marshak Richard

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 81d
  SEC Form 4 filed by Stevens Jennifer

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 81d
  SEC Form 4 filed by Szela Mary T

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 106d
  Director Gordon Gary B. bought $40,000 worth of shares (9,756 units at $4.10) (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 106d
  Chief Financial Officer Patience David bought $14,994 worth of shares (3,657 units at $4.10), increasing direct ownership by 1% to 268,657 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 106d
  CEO and President Szela Mary T bought $124,997 worth of shares (30,487 units at $4.10), increasing direct ownership by 4% to 773,289 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 106d
  Director Valle William bought $124,997 worth of shares (30,487 units at $4.10) (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 106d
  Director Stansky Michael P bought $1,480,502 worth of shares (361,098 units at $4.10), increasing direct ownership by 45% to 787,132 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 118d
  SEC Form 4 filed by Director Stansky Michael P

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 118d
  New insider Stansky Michael P claimed ownership of 625,732 shares (SEC Form 3)

  3 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 196d
  Chief of Research Cox Bryan F. was granted 40,000 shares, increasing direct ownership by 32% to 166,599 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 196d
  Chief of Clinical Operations Devlin Jodi was granted 50,000 shares, increasing direct ownership by 99% to 100,571 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 196d
  CEO and President Szela Mary T was granted 550,000 shares, increasing direct ownership by 285% to 742,802 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 196d
  Chief Regulatory Officer Stevens Jennifer was granted 50,000 shares, increasing direct ownership by 64% to 127,640 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 196d
  Chief Commercial Officer Marshak Richard was granted 60,000 shares, increasing direct ownership by 111% to 113,854 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 196d
  Chief Financial Officer Patience David was granted 65,000 shares, increasing direct ownership by 32% to 265,000 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 284d
  SEC Form 4 filed by Chief Financial Officer Patience David

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 298d
  Chief Financial Officer Patience David was granted 200,000 shares (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 334d
  SEC Form 3 filed by new insider Patience David

  3 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 347d
  SEC Form 4 filed by Director Desai Arjun Jj

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 347d
  SEC Form 4 filed by Director Gordon Gary B.

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 347d
  SEC Form 4 filed by Director Hicks Kerry R

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 347d
  SEC Form 4 filed by Director Matlin David J

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 347d
  SEC Form 4 filed by Director Murphy Sean

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 347d
  SEC Form 4 filed by Director Valle William

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 347d
  SEC Form 4 filed by Director Wahlstrom Mats

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 384d
  Chief Financial Officer Young James Emmett was granted 13,175 shares, increasing direct ownership by 36% to 49,663 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 384d
  Chief of Research Cox Bryan F. was granted 15,722 shares and sold $24,678 worth of shares (4,764 units at $5.18), increasing direct ownership by 10% to 119,415 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 384d
  Chief of Clinical Operations Devlin Jodi was granted 24,131 shares and sold $24,678 worth of shares (4,764 units at $5.18), increasing direct ownership by 58% to 52,764 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 384d
  Chief Commercial Officer Marshak Richard was granted 21,428 shares and sold $34,172 worth of shares (6,597 units at $5.18), increasing direct ownership by 27% to 69,101 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 384d
  Director Murphy Sean was granted 44,884 shares, increasing direct ownership by 57% to 123,989 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 384d
  Chief Regulatory Officer Stevens Jennifer was granted 28,455 shares and sold $45,087 worth of shares (8,704 units at $5.18), increasing direct ownership by 34% to 77,640 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 475d
  Chief Manuf, Strategy&Bus Dev. Murphy Sean was granted 15,817 shares, increasing direct ownership by 25% to 79,105 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 475d
  Chief Financial Officer Young James Emmett was granted 14,762 shares, increasing direct ownership by 68% to 36,488 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 475d
  CHIEF REGULATORY OFFICER Stevens Jennifer was granted 14,481 shares, increasing direct ownership by 33% to 57,889 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 475d
  CHIEF OF RESEARCH Cox Bryan F. was granted 11,450 shares, increasing direct ownership by 12% to 108,457 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 475d
  Chief Commercial Officer Marshak Richard was granted 7,644 shares, increasing direct ownership by 16% to 54,270 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 475d
  CEO AND PRESIDENT Szela Mary T was granted 21,089 shares, increasing direct ownership by 5% to 465,348 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 475d
  Chief of Clinical Operations Devlin Jodi was granted 5,272 shares, increasing direct ownership by 19% to 33,397 units (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 483d
  SEC Form 4 filed by Director Matlin David J

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 483d
  SEC Form 4 filed by Director Wahlstrom Mats

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 483d
  SEC Form 4 filed by Large owner Frankenius Equity Ab

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 488d
  Chief Financial Officer Young James Emmett bought $33,900 worth of shares (6,000 units at $5.65) (SEC Form 4)

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)
• 494d
  SEC Form 4 filed by Director Gordon Gary B.

  4 - TriSalus Life Sciences, Inc. (0001826667) (Issuer)